A web tool for age-period-cohort analysis of cancer incidence and mortality rates

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 11, 2014, Pages 2296-2302

  Rosenberg, Philip S ^a,b   Check, David P ^a   Anderson, William F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Biostatistics Branch   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; COHORT ANALYSIS; COMPUTER ANALYSIS; COMPUTER PROGRAM; FEMALE; HUMAN; INTERNET; LEARNING CURVE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MIDDLE AGED; NEOPLASM; PROSTATE CANCER; TEACHING; VERY ELDERLY; WEB BROWSER; HEALTH SURVEY; INCIDENCE; MORTALITY; NEOPLASMS; SOFTWARE; STATISTICAL ANALYSIS;

AGE FACTORS; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; HUMANS; INCIDENCE; INTERNET; LEARNING CURVE; NEOPLASMS; POPULATION SURVEILLANCE; SOFTWARE;

EID: 84919644816     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0300     Document Type: Article

References (52)

1. International Agency for Research on Cancer. Cancer incidence in five continents, volume IX. In:Curado MP, Edwards B, Shin HR, Ferlay J, Heanue M, Boyle P, et al., editors. Lyon, France: International Agency for Research on Cancer; 2009.
2. Eheman C, Henley SJ, Ballard-Barbash R, Jacobs EJ, Schymura MJ, Noone AM, et al. Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 2012;118:2338-66.
3. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012;13:790-801.
4. Devesa SS, Donaldson J, Fears T. Graphical presentation of trends in rates. Am J Epidemiol 1995;141:300-4.
5. Robertson C, Boyle P. Age-period-cohort models of chronic disease rates. II: graphical approaches. Stat Med 1998;17:1325-39.
6. Fay MP, Tiwari RC, Feuer EJ, Zou Z. Estimating average annual percent change for disease rates without assuming constant change. Biometrics 2006;62:847-54.
7. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19:335-51.
8. Bergstrom R, Adami HO, Mohner M, Zatonski W, Storm H, Ekbom A, et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Nat Cancer Inst 1996;88:727-33.
9. Verhoeven R, Houterman S, Kiemeney B, Koldewijn E, Coebergh JW. Testicular cancer: marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 1970. Int J Cancer 2008;122:639-42.
10. Liu S, Semenciw R, Waters C, Wen SW, Mery LS, Mao Y. Clues to the aetiological heterogeneity of testicular seminomas and non-seminomas: time trends and age-period-cohort effects. Int J Epidemiol 2000;29:826-31.
11. Bray F, Richiardi L, Ekbom A, Forman D, Pukkala E, Cuninkova M, et al. Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev 2006;15:652-8.
12. Spix C, Eletr D, Blettner M, Kaatsch P. Temporal trends in the incidence rate of childhood cancer in Germany 1987- 2004. Int J Cancer 2008;122:1859-67.
13. McNally RJ, Cairns DP, Eden OB, Kelsey AM, Taylor GM, Birch JM. Examination of temporal trends in the incidence of childhood leukaemias and lymphomas provides aetiological clues. Leukemia 2001;15:1612-8.
14. Svensson E, Moller B, Tretli S, Barlow L, Engholm G, Pukkala E, et al. Early life events and later risk of colorectal cancer: age-period-cohort modelling in the Nordic countries and Estonia. Cancer Causes Control 2005;16:215-23.
15. Chu KC, Tarone RE, Brawley OW. Breast cancer trends of black women compared with white women. Arch Fam Med 1999;8:521-8.
16. Sim X, Ali RA, Wedren S, Goh DL, Tan CS, Reilly M, et al. Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968-2002. BMC Cancer 2006;6:261.
17. Holford TR, Cronin KA, Mariotto AB, Feuer EJ. Changing patterns in breast cancer incidence trends. J Natl Cancer Inst Monogr 2006:19-25.
18. McNally RJ, Rowland D, Roman E, Cartwright RA. Age and sex distributions of hematological malignancies in the U.K. Hematol Oncol 1997;15:173-89.
19. Bacher U, Kern W, Schnittger S, Hiddemann W, Haferlach T, Schoch C. Population-based age-specific incidences of cytogenetic subgroups of acute myeloid leukemia. Haematologica 2005;90:1502-10.
20. Tarone RE, Chu KC. The greater impact of menopause on ER- than ER+ breast cancer incidence: a possible explanation (United States). Cancer Causes Control 2002;13:7-14.
21. Anderson WF, Chu KC, Chang S, Sherman ME. Comparison of agespecific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 2004;13:1128-35.
22. Chu KC, Tarone RE, Chow WH, Hankey BF, Ries LA. Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst 1994;86:997-1006.
23. Corrao G, Ferrari P, Zambon A, Torchio P, Arico S, Decarli A. Trends of liver cirrhosis mortality in Europe, 1970-1989: age-period-cohort analysis and changing alcohol consumption. Int J Epidemiol 1997;26:100-9.
24. Jemal A, Ma J, Rosenberg PS, Siegel R, Anderson WF. Increasing lung cancer death rates among young women in southern and midwestern states. J Clin Oncol 2012;30:2739-44.
25. de Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 2003;107:119-26.
26. Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Moller H. Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 2006;118:3099-111.
27. Cayuela A, Rodriguez-Dominguez S, Lopez-Campos JL, Vigil E. Age-period-cohort analysis of lung cancer mortality rates in Andalusia, 1975-2004. Lung Cancer 2007;57:261-5.
28. Holford TR, Armitage P, Colton T. Age-period-cohort analysis. Encyclopedia of Biostatistics. John Wiley & Sons, Ltd.; 2005. p. 82-99.
29. Clayton D, Schifflers E. Models for temporal variation in cancer rates. I: age-period and age-cohort models. Stat Med 1987;6:449-67.
30. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med 1987;6:469-81.
31. Robertson C, Boyle P. Age-period-cohort analysis of chronic disease rates. I: modelling approach. Stat Med 1998;17:1305-23.
32. Tarone RE, Chu KC. Evaluation of birth cohort patterns in population disease rates. Am J Epidemiol 1996;143:85-91.
33. Tarone RE, Chu KC. Nonparametric evaluation of birth cohort trends in disease rates. J Epidemiol Biostat 2000;5:177-91.
34. Rosenberg PS, Anderson WF. Age-period-cohort models in cancer surveillance research: ready for prime time? Cancer Epidemiol Biomarkers Prev 2011;20:1263-8.
35. Anderson WF, Rosenberg PS, Menashe I, Mitani I, Pfeiffer RM. Agerelated crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst 2008;100:11.
36. Speaks C, McGlynn KA, Cook MB. Significant calendar period deviations in testicular germ cell tumors indicate that postnatal exposures are etiologically relevant. Cancer Causes Control 2012;23:1593-8.
37. Yang HP, Anderson WF, Rosenberg PS, Trabert B, Gierach GL, Wentzensen N, et al. Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States. J Clin Oncol 2013;31:2146-51.
38. Ma J, Siegel R, Jemal A. Pancreatic cancer death rates by race among US men and women, 1970 - 2009. J Natl Cancer Inst 2013;105:1694-700.
39. Rosenberg PS, Wilson KL, Anderson WF. Are incidence rates of adult leukemia in the United States significantly associated with birth cohort? Cancer Epidemiol Biomarkers Prev 2012;21:2159-66.
40. Mbulaiteye SM, Anderson WF, Bhatia K, Rosenberg PS, Linet MS, Devesa SS. Trimodal age-specifi c incidence patterns for Burkitt lymphoma in the United States, 1973-2005. Int J Cancer 2010;126:1732-9.
41. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 2013;31:4550-9.
42. Anderson WF, Rosenberg PS, Petito L, Katki HA, Ejlertsen B, Ewertz DM, et al. Divergent estrogen receptor positive and negative breast cancer trends and etiologic heterogeneity in Denmark. Int J Cancer 2013;133:2201-6.
43. Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics 1983;39:311-24.
44. Holford TR. Approaches to fitting age-period-cohort models with unequal intervals. Stat Med 2006;25:977-93.
45. Rosenberg PS, Anderson WF. Proportional hazards models and age-period-cohort analysis of cancer rates. Stat Med 2010;29:1228-38.
46. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37 Suppl 8:S4-66.
47. Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol 2009;28:232-9.
48. Anderson WF, Pfeiffer RM, Tucker MA, Rosenberg PS. Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma. Cancer 2009;115:4176-85.
49. Grimley PM, Matsuno RK, Rosenberg PS, Henson DE, Schwartz AM, Anderson WF. Qualitative age interactions between low-grade and high-grade serous ovarian carcinomas. Cancer Epidemiol Biomarkers Prev 2009;18:2256-61.
50. Reimers LL, Anderson WF, Rosenberg PS, Henson DE, Castle PE. Etiologic heterogeneity for cervical carcinoma by histopathologic type, using comparative age-period-cohort models. Cancer Epidemiol Biomarkers Prev 2009;18:792-800.
51. Kilfoy BA, Devesa SS, Ward MH, Zhang Y, Rosenberg PS, Holford TR, et al. Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev 2009;18:1092-100.
52. Carstensen B. Age-period-cohort models for the Lexis diagram. Stat Med 2007;26:3018-45.